This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock IDXG vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, and BTCYShould you be buying Interpace Biosciences stock or one of its competitors? The main competitors of Interpace Biosciences include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Biotricity (BTCY). Interpace Biosciences vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Biotricity Labcorp (NYSE:LH) and Interpace Biosciences (NASDAQ:IDXG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations. Which has higher valuation and earnings, LH or IDXG? Labcorp has higher revenue and earnings than Interpace Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.68$746M$9.0628.85Interpace Biosciences$40.21M0.09$800KN/AN/A Does the media refer more to LH or IDXG? In the previous week, Labcorp had 32 more articles in the media than Interpace Biosciences. MarketBeat recorded 34 mentions for Labcorp and 2 mentions for Interpace Biosciences. Labcorp's average media sentiment score of 0.94 beat Interpace Biosciences' score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 19 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Interpace Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is LH or IDXG more profitable? Interpace Biosciences has a net margin of 10.39% compared to Labcorp's net margin of 5.66%. Labcorp's return on equity of 15.45% beat Interpace Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% Interpace Biosciences 10.39%-8.09%37.14% Which has more volatility & risk, LH or IDXG? Labcorp has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Interpace Biosciences has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Do analysts prefer LH or IDXG? Labcorp currently has a consensus price target of $289.58, suggesting a potential upside of 10.81%. Given Labcorp's stronger consensus rating and higher possible upside, analysts clearly believe Labcorp is more favorable than Interpace Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.62Interpace Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders have more ownership in LH or IDXG? 95.9% of Labcorp shares are owned by institutional investors. Comparatively, 5.7% of Interpace Biosciences shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 5.5% of Interpace Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryLabcorp beats Interpace Biosciences on 11 of the 14 factors compared between the two stocks. Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXG vs. The Competition Export to ExcelMetricInterpace BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.66M$65.78M$5.49B$9.52BDividend YieldN/AN/A4.73%4.09%P/E RatioN/A6.2128.7823.81Price / Sales0.09109.49372.2066.04Price / Cash1.9918.4135.4557.96Price / Book-0.067.368.275.54Net Income$800K-$25.86M$3.25B$259.28M Interpace Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXGInterpace BiosciencesN/A$0.83-3.5%N/A-31.2%$3.66M$40.21M0.00152LHLabcorp4.8252 of 5 stars$252.34+3.8%$276.08+9.4%+12.0%$20.34B$13.01B29.1770,000Insider TradeDGXQuest Diagnostics4.9425 of 5 stars$178.13+7.0%$186.07+4.5%+15.7%$18.58B$9.87B22.5256,000Positive NewsAnalyst UpgradeInsider TradeHigh Trading VolumeDVADaVita4.4526 of 5 stars$146.09+4.8%$164.50+12.6%+0.7%$10.53B$12.82B14.4876,000News CoveragePositive NewsUpcoming EarningsCHEChemed4.972 of 5 stars$453.96+1.0%$645.00+42.1%-29.0%$6.57B$2.43B22.1115,695Trending NewsEarnings ReportAnalyst ForecastCRVLCorVel1.0735 of 5 stars$93.28-2.9%N/A-15.2%$4.94B$895.59M50.795,075News CoverageUpcoming EarningsAMEDAmedisys2.9311 of 5 stars$97.97+0.3%$100.75+2.8%+0.4%$3.21B$2.35B36.1519,000Trending NewsEarnings ReportAnalyst RevisionMDPediatrix Medical Group2.7225 of 5 stars$12.76+0.9%$16.67+30.6%+45.1%$1.09B$2.01B-12.634,305Positive NewsUpcoming EarningsAMNAMN Healthcare Services4.496 of 5 stars$19.98+7.6%$32.08+60.6%-73.3%$710.95M$2.98B-4.612,968Upcoming EarningsCCRNCross Country Healthcare3.5875 of 5 stars$13.37+0.1%$17.93+34.1%-25.7%$437.98M$1.34B-25.238,205News CoverageBTCYBiotricityN/A$0.51+6.3%N/A-40.4%$12.71M$12.06M-0.4740 Related Companies and Tools Related Companies Labcorp Competitors Quest Diagnostics Competitors DaVita Competitors Chemed Competitors CorVel Competitors Amedisys Competitors Pediatrix Medical Group Competitors AMN Healthcare Services Competitors Cross Country Healthcare Competitors Biotricity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDXG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDXG Stock Alerts